Evidence map›Paper›PMID 30670433›Full record

ArticleAntimicrobial agents and chemotherapy2019

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies.

Michael Trang, Julie D Seroogy, Scott A Van Wart, Sujata M Bhavnani, Aryun Kim, Jacqueline A Gibbons, Paul G Ambrose, Christopher M Rubino

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Michael TrangInstitute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
Julie D SeroogyAchaogen, Inc., South San Francisco, California, USA.
Scott A Van WartInstitute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
Sujata M BhavnaniInstitute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
Aryun KimAchaogen, Inc., South San Francisco, California, USA.
Jacqueline A GibbonsAchaogen, Inc., South San Francisco, California, USA jgibbons@achaogen.com.
Paul G AmbroseInstitute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
Christopher M RubinoInstitute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
Institute for Clinical Pharmacodynamics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plazomicin is an aminoglycoside with activity against multidrug-resistant

Indexed as

AdolescentAdultAgedAged, 80 and overAminoglycosidesAnti-Bacterial AgentsClinical Trials as TopicFemaleHumansKidneyMaleMiddle AgedPyelonephritisSisomicinUrinary Tract InfectionsYoung AdultAminoglycosidesAnti-Bacterial AgentsplazomicinSisomicinaminoglycosidesplazomicinpopulation pharmacokinetics

Identifiers

PMID30670433
PMCPMC6496156
OpenAlexW2908827088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.